Amarin Corp Plcuk (AMRN) Free Cash Flow (2010 - 2026)
Amarin Corp Plc\Uk (AMRN) posted quarterly Free Cash Flow of $3.7 million for Q2 2026, down 77.99% year-over-year from $16.6 million in Q2 2025, and down 43.14% quarter-over-quarter from $6.4 million in Q1 2026.
Amarin Corp Plcuk (AMRN) Free Cash Flow (2010 - 2026) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Free Cash Flow for 17 consecutive years, with $3.7 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Free Cash Flow fell 77.99% year-over-year to $3.7 million; the TTM figure through Jun 2026 stood at $12.8 million (up 212.29% YoY), while the FY2025 annual figure was $6.9 million, up 122.3% from the prior year.
- Free Cash Flow eased to $3.7 million in Q2 2026 per AMRN's latest filing, from $6.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $16.6 million in Q2 2025 and bottomed at -$98.8 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$10.4 million across 5 years, with a median of -$2.5 million in 2024.
- Annual changes were most pronounced in 2024 — Free Cash Flow slumped 2075.9% — and 2025, when it jumped 713.75%.
- Amarin Corp Plc\Uk's Free Cash Flow stood at $1.6 million in 2022, then tumbled by 139.3% to -$610000.0 in 2023, then plunged by 2075.9% to -$13.3 million in 2024, then jumped by 215.51% to $15.3 million in 2025, then sank by 76.1% to $3.7 million in 2026.
- Business Quant data shows AMRN's Free Cash Flow at $3.7 million in Q2 2026, $6.4 million in Q1 2026, and $15.3 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 7.30 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.11 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 4.48 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 5.56 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -1.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 3.49 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 3.43 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 302.00 Mn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 440.07 Mn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.66 Mn |
| Jun 30, 2026 | 3.66 Mn |
| Mar 31, 2026 | 6.44 Mn |
| Mar 31, 2026 | 6.44 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Dec 31, 2025 | 15.33 Mn |
| Sep 30, 2025 | -12.67 Mn |
| Sep 30, 2025 | -12.67 Mn |
| Jun 30, 2025 | 16.65 Mn |
| Jun 30, 2025 | 16.65 Mn |
| Mar 31, 2025 | -12.42 Mn |
| Mar 31, 2025 | -12.42 Mn |
| Dec 31, 2024 | -13.27 Mn |
| Dec 31, 2024 | -13.27 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Jun 30, 2024 | -2.71 Mn |
| Jun 30, 2024 | -2.71 Mn |
| Mar 31, 2024 | -12.57 Mn |
| Mar 31, 2024 | -12.57 Mn |